| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 42 |
| 性別 | 男女 |
| 年齢 | 18-29, 30-44 |
| 体型 | 肥満 |
この研究の注釈：
Supplementation of 4,000mg inositol daily for a period of 12-16 weeks in women with PCOS was able to improve tolerance to glucose and glucose handling (as well as reduce the amount of insulin secreted in response to a meal) with minor benefits to cardiovascular health as well.
Myo-inositol Administration Positively Affects Hyperinsulinemia And Hormonal Parameters In Overweight Patients With Polycystic Ovary Syndrome
| 効果 | 減少 |
| 試験方法 | 二重盲検法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 20 |
| 性別 | 女性 |
| 年齢 | 18-29, 30-44 |
| 体型 | 肥満 |
この研究の注釈：
2,000mg inositol daily in overweight women with PCOS
Differential Insulin Response To Myo-inositol Administration In Obese Polycystic Ovary Syndrome Patients
| 効果 | 減少 |
| 試験方法 | コホート法 |
| 試験期間 | 1-6 ヶ月 |
| 被験者数 | 42 |
| 性別 | 女性 |
| 年齢 | 18-29, 30-44 |
| 体型 | 肥満 |
この研究の注釈：
Supplementation of 2,000mg inositol (INOFERT) once daily for eight weeks in obese women with PCOS was able to improve insulin sensitivity and other biomarkers of glucose metabolism only in those with higher circulating insulin concentrations.
Supplementation of 2,000mg inositol (INOFERT) once daily for eight weeks in obese women with PCOS was able to improve insulin sensitivity and other biomarkers of glucose metabolism only in those with higher circulating insulin concentrations.
No placebo control was used in this study.